Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 浙江花园生物医药股份有限公司成立于2000年12月，是国家级高新技术企业、国家高技术产业化示范项目、国家资源综合利用项目。公司于2014年10月9日在深圳证券交易所创业板挂牌上市。经过二十多年的发展，已经完成了维生素D3全产业链的布局。公司四大类产品精制羊毛脂、羊毛脂胆固醇、维生素D3、25-羟基维生素D3的产能规模都处于全球领先位置，拥有市场主导权。花园生物将以市场创新、文化创新、技术创新为引领，坚定不移推动化学合成、生物合成双布局，不断推进“一纵一横”发展战略。未来公司还将开发全活性维生素D3系列产品，把公司建设成为医药大健康领域具有影响的高科技企业。公司拥有三大核心技术，NF胆固醇生产工艺、维生素D3生产工艺、25-羟基维生素D3生产工艺，分别荣获国家技术发明二等奖、国家科技进步二等奖、浙江省科技进步一等奖。2018年，由于下沙生产基地搬迁，并为了满足国家环保政策的新要求，公司未雨绸缪，决定在金华经济技术开发区建设金西科技园，园区占地771亩，公司的生产基地将集中至该园区。公司融合20多年的技术和装备积累，采用先进的自控技术，把金西科技园建设成为高度数字化、智能化的现代化工厂。2021年初，面对新的机遇和挑战，公司制定了“一纵一横”发展新目标，一纵：继续打造完整的维生素D3上下游产业链，一横：利用公司在全球维生素市场的行业优势及营销通道，开展兼并整合，促使公司的经营规模和经营业绩迈上新的台阶。
Main Business 维生素D3上下游系列产品的研发、生产和销售。
Legal Representative 邵徐君
Top Executives
董事长：邵徐君
副董事长：魏忠岚,马焕政
董事：邵钦祥,魏忠岚,方福生,喻铨衡
独立董事：严建苗,杨启炜,厉国威
Top 5 Shareholder
Shareholder name Nature Holding Date
浙江祥云科技股份有限公司流通A股26.57%30/09/2024
邵君芳流通A股3.06%30/09/2024
浙江花园生物医药股份有限公司－2022年员工持股计划流通A股1.41%30/09/2024
香港中央结算有限公司流通A股1.15%30/09/2024
中科先行（北京）资产管理有限公司流通A股0.92%30/09/2024
Company Secretary 喻铨衡
Solicitors 北京市浩天信和律师事务所
Auditors 大华会计师事务所（特殊普通合伙）
Tel No 0579-86271622
Fax No 0579-86271615
Website www.hybiotech.com
Email gkstock@hybiotech.cn
Company Address
Register: 浙江省金华市东阳市南马镇花园村
Office: 浙江省金华市东阳市南马镇花园村
Listing Date 09/10/2014
Shares Capital
Shares Capital: 543,467,103
Total A Share: 543,467,103
Listed A Share: 534,683,104
Non-tradable A Share: 8,783,999
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.350
DPS(RMB)* ¥ 0.071
NBV Per Share(RMB)* ¥ 4.772
Market Capitalization(RMB) 8.229B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.